Neuromuscular blocking activity of cyclic and acyclic bis-quaternary ammonium analogues of mivacurium chloride in the cat

European Journal of Pharmaceutical Sciences

Volumn 5, Issue 5, 1997, Pages 253-266

  Patel, Sanjay S ^a   Maehr, R Brandt ^a   Savarese, John J ^b   Jackson, Mary M ^a   Wastila, William B ^a   Wisowaty, James C ^a  

^a Burroughs Wellcome Co   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Acyclic bis quaternary ammonium compounds; bis 1 Benzyltetrahydroisoquinolinium esters; Cardiovascular effects; Neuromuscular blocking agents; Vagal inhibition

Indexed keywords

AMMONIUM DERIVATIVE; MIVACURIUM; QUATERNARY AMMONIUM DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; AUTONOMIC DYSFUNCTION; CARDIOVASCULAR EFFECT; CAT; DRUG EFFECT; DRUG POTENCY; DRUG SAFETY; DRUG SYNTHESIS; NEUROMUSCULAR BLOCKING; NONHUMAN; PRIORITY JOURNAL;

EID: 0030921591     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(97)00020-1     Document Type: Article

References (22)

1. Bartkowski, R.R., Witkowski, T.A., Azad, S., Lessin, J., Marr, A., 1993. Rocuronium onset of action: a comparison with atracurium and vecuronium. Anesth. Analg. 77, 574-578.
2. Basta, S.J., 1992. Modulation of histamine release by neuromuscular blocking drugs. Curr. Opin. Anesthesiol. 5, 572-576.
3. Belmont, M.R., Maehr, R.B., Wastila, W.B., Savarese, J.J., 1993. Pharmacodynamics and pharmacokinetics of benzylisoquinolinium (curare-like) neuromuscular blocking drugs. In: Benumof, J.L., Partridge, B.L. (Eds.), Anesthesiology Clinics of North America, Vol. 11 (2), WB Saunders, Philadelphia, pp. 251-281.
4. Bowman, W.C., Rodger, I.W., Houston, J., Marshall, R.J., McIndewar, I., 1988. Structure: action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anesthetized cat. Anesthesiology 69, 57-62.
5. Bowman, W.C., 1980. Prejunctional and postjunctional cholinoceptors at the neuromuscular junction. Anesth. Analg. 59, 935-943.
6. Brown, G.B., Armstrong, M.D., Moyer, A.W., Anslow, W.P., Baker, B.R., Querry, M.V., Bernstein, S., Safir, S.R., 1947. Biotin. III. 2-(D-carboxybutyl)thiophane-3,4-dicarboxylic acid. J. Org. Chem. 12, 160-166.
7. Brown, H.C., Heim, P., 1973. Selective reductions. XVIII. The fast reaction of primary, secondary, and tertiary amides with diborane. A simple, convenient procedure for the conversion of amides to the corresponding amines. J. Org. Chem. 38(3), 912-916.
8. Dewar, G.H., Marshall, I.G., Patel, S.S., 1994. Chemodegradable neuromuscular blocking agents-2: Quaternary ester and ketone salts. Pharm. Sci. Commun. 4(2), 81-96.
9. Eisenbraun, E.J., 1973. Cycloöctanone. Org. Synth., Vol. V. John Wiley and Sons, New York, pp. 310-314.
10. Kopman, A.F., 1989. Gallamine, pancuronium, and d-tubocurarine compared: Is onset related to drug potency?. Anesthesiology 70, 915-920.
11. Law Min, J.C., Bekavac, I., Glavinovic, M.I., Donati, F., Bevan, D.R., 1992. Iontophoretic study of speed of action of various muscle relaxants. Anesthesiology 77, 351-356.
12. Maehr, R.B., Belmont, M.R., Wray, D.L., Savarese, J.J., Wastila, W.B., 1991. Autonomic and neuromuscular effects of mivacurium and isomers in cats. Anesthesiology 75(3A), A772.
13. Martin-Smith, M., 1971. Rational elements in the development of superior neuromuscular blocking agents. In: Ariens, E.J. (Ed.), Drug Design, Vol. II. Academic Press, London, pp. 453-530.
14. Patel, S.S., Maehr, R.B., Wastila, W.B., Savarese, J.J., Wisowaty, J.C., 1996. Neuromuscular blocking activity of bis-4-benzyltetrahydroisoquinolinium esters in the cat. Eur. J. Pharm. Sci. 4(2), 63-71.
15. Stenlake, J.B., Waigh, R.D., Dewar, G.H., Hughes, R., Chapple, D.J., Coker, G.G., 1981. Biodegradable neuromuscular blocking agents. Part 4. Atracurium beylate and related polyakylene di-esters. Eur. J. Med. Chem. 16(6), 515-524.
16. Stenlake, J.B., Waigh, R.D., Dewar, G.H., Dhar, N.C., Hughes, R., Chapple, D.J., Lindon, J.C., Ferrige, A.G., 1984. Biodegradable neuromuscular blocking agents. Part 6. Stereochemical studies on atracurium and related polyakylene di-esters. Eur. J. Med. Chem. 19(5), 441-450.
17. Veysoglu, T., Mitscher, L.A. and Swayze, J.K., 1980. A convenient method for the control of selective ozonizations of olefins Synthesis 807-810.
18. Wang, Z., Zvlichovsky, G., 1990. Selectivity in ozonolyses of cyclic 1,3-dienes. Tetrahedron Lett. 3139, 5579-5582.
19. Wierda, J.M.K.H., De Wit, A.P.M., Kuizenga, K., Agoston, S., 1990. Clinical observations on the neuromuscular blocking action of ORG 9426, a new steroidal non-depolarising agent. Br. J. Anaesth. 64, 521-523.
20. Wierda, J.M.K.H., van den Broek, L., Proost, J.H., Verbaan, B.W., Hennis, P.M., 1993. Time course of action and endotracheal intubating conditions of Org 9487, a new short-acting steroidal muscle relaxant; a comparison with succinylcholine. Anesth. Analg. 77, 579-584.
21. Wierda, J.M.K.H., Proost, J.H., Muir, A.W, Marshall, R.J., 1993. Design of drugs for rapid onset. Anaesth. Pharmacol. Rev. 1, 57-68.
22. Wierda, J.M.K.H., Beaufort, A.M., Kleef, U.W, Smeulers, N.J., Agoston, S., 1994. Preliminary investigation of the clinical pharmacology of three short-acting non-depolarising neuromuscular blocking agents, Org 9453, Org 9489 and Org 9487. Can. J. Anaesth. 41, 213-220.